RT by @EMA_News: Evolution of #COVID19 variants remain a significant threat.
A joint procurement procedure for mRNA vaccines has been launched to enhance the #preparedness of participating countries.
Signature of a contract is foreseen in Spring, with no obligation to purchase.
🐦🔗: https://nitter.cz/EC_HERA/status/1747185167830012110#m
[2024-01-16 09:12 UTC]
At its Jan meeting, our safety committee the
https://nitter.cz/search?q=%23PRAC
:
✅recommended measures to address a potential risk of neurodevelopmental disorders in children born to men treated with
https://nitter.cz/search?q=%23valproate
✅started a review of
https://nitter.cz/search?q=%23CARTcell
💊
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-january-2024
🐦🔗: https://nitter.cz/EMA_News/status/1745777485797622139#m
[2024-01-12 11:59 UTC]
Don't miss the EMA/
https://nitter.cz/EORTC
workshop exploring how patient reports on their own health and quality of life can inform regulatory decisions on
https://nitter.cz/search?q=%23cancertreatments
-
https://europa.eu/!TVfryM
📅 29 Feb
✍15 Jan deadline for in-person registration
💻 Online registration open until 16 Feb
🐦🔗: https://nitter.cz/EMA_News/status/1745702150221537525#m
[2024-01-12 07:00 UTC]
RT by @EMA_News: How to understand infectious diseases' dynamics? How to track the pathogen evolution (such as e.x. #COVID19 variants?)
Listen to our brand new #ECDConAir podcast episode on #GenomicEpidemiology & the ECDC's #GenEpiBioTrain training here:
https://bit.ly/ECDConAir45
🐦🔗: https://nitter.cz/ECDC_EU/status/1745011714758705191#m
[2024-01-10 09:16 UTC]
RT by @EMA_News: 📢For all health stakeholders:
How to best exchange the latest ⚕️health-related news, increase visibility of health initiatives and build up strong networks?
Use the EU Health Policy Platform, #EUHPP, with over 6⃣0⃣0⃣0⃣ members.
👉More information: https://europa.eu/!chjPQH
🐦🔗: https://nitter.cz/EU_Health/status/1745011781725004245#m
[2024-01-10 09:16 UTC]
Many people struggling with depression need treatments with better efficacy, improved safety & more personalised profiles.
EMA encourages developers to share comments on the revised guideline on clinical investigation of
https://nitter.cz/search?q=%23antidepressants
by 31/03/2024.
➡️
https://www.cambridge.org/core/journals/european-psychiatry/article/new-ema-guideline-on-antidepressants-a-guide-for-researchers-and-drug-developers/37E69FCD252D9CE5510BEF035E5B253F
🐦🔗: https://nitter.cz/EMA_News/status/1745005736923443221#m
[2024-01-10 08:52 UTC]
Register now to participate online in the two-day workshop on
https://nitter.cz/search?q=%23PatientRegistries
📅12-13 February
👉Deadline: 12 January
🖥️
https://europa.eu/!PkxMYK
🐦🔗: https://nitter.cz/EMA_News/status/1744396042584703360#m
[2024-01-08 16:30 UTC]
RT by @EMA_News: #DYK that during the acute phase of the #COVID19 pandemic
🔸#HPV vaccine uptake ⬇️ 10-24% in some countries in the Region
🔸47% of reporting countries indicated some level of disruption in #screening
Action: Invest in health systems so that they are agile & resilient to shocks!
🐦🔗: https://nitter.cz/WHO_Europe/status/1743195905715511414#m
[2024-01-05 09:01 UTC]
RT by @EMA_News: Following annual review of our eligibility to remain as one of @EMA_News patients and consumers organisations, we are pleased to have received news that we continue to meet strict eligibility criteria and can continue to be involved in EMA activities
https://www.alzheimer-europe.org/news/alzheimer-europe-continues-comply-european-medicines-agencys-strict-eligibility-criteria-0
🐦🔗: https://nitter.cz/AlzheimerEurope/status/1743236246296572218#m
[2024-01-05 11:41 UTC]
RT by @EMA_News: #CervicalCancer is preventable.
In addition to #HPV vaccination, regular screening helps detect & protect women from cervical cancer.
🐦🔗: https://nitter.cz/WHO_Europe/status/1742098423954788592#m
[2024-01-02 08:20 UTC]
Together we can help prevent antibiotic
https://nitter.cz/search?q=%23shortages
this winter ❄ !
Learn more ⬇️
https://nitter.cz/search?q=%23medicines
https://nitter.cz/search?q=%23antibiotics
https://nitter.cz/search?q=%23publichealth
🐦🔗: https://nitter.cz/EMA_News/status/1739934149203349738#m
[2023-12-27 09:00 UTC]
Don’t forget to register for the EMA/
https://nitter.cz/EORTC
workshop on soft tissue and bone
https://nitter.cz/search?q=%23sarcoma
.
🗓️ Deadline 8 January:
https://www.ema.europa.eu/en/events/ema-and-eortc-multi-stakeholder-workshop-soft-tissue-and-bone-sarcoma
https://nitter.cz/search?q=%23cancer
https://nitter.cz/search?q=%23research
https://nitter.cz/search?q=%23medicines
🐦🔗: https://nitter.cz/EMA_News/status/1737735905933156746#m
[2023-12-21 07:25 UTC]
https://nitter.cz/search?q=%23JustPublished
: Midterm report on the European medicines agencies network strategy!
It offers a snapshot of key achievements and concrete deliverables by EU medicines regulators as they implement the strategy planned until 2025.
➡️
https://www.ema.europa.eu/en/news/midterm-report-2025-network-strategy-highlights-good-progress-during-critical-period-pandemic
https://nitter.cz/search?q=%23AMR
https://nitter.cz/search?q=%23COVID19
🐦🔗: https://nitter.cz/EMA_News/status/1737495400578224395#m
[2023-12-20 15:29 UTC]
Emer Cooke's end-of-year-message ‼️
Our Executive Director takes stock of what 2023 has meant for the work of the Agency.
Read the statement here 👇
https://www.ema.europa.eu/en/news/goodbye-2023-when-optimism-came-back
🐦🔗: https://nitter.cz/EMA_News/status/1737122216897081739#m
[2023-12-19 14:46 UTC]
📢Just published: workplan on
https://nitter.cz/search?q=%23ArtificialIntelligence
to 2028 will help medicines regulators in Europe embrace the opportunities of AI while managing the risks➡️
https://europa.eu/!9RjYwf
🐦🔗: https://nitter.cz/EMA_News/status/1736742921913676163#m
[2023-12-18 13:39 UTC]
Highlights of EMA’s December Management Board meeting are out! Read more about:
✔️ EMA’s 2024 work programme
✔️ Progress with the implementation of the veterinary
https://nitter.cz/search?q=%23medicines
and
https://nitter.cz/search?q=%23clinicaltrials
regulations.
https://www.ema.europa.eu/en/news/ema-management-board-highlights-december-2023-meeting
🐦🔗: https://nitter.cz/EMA_News/status/1735696331761504491#m
[2023-12-15 16:20 UTC]
📢 The
https://nitter.cz/search?q=%23CHMP
recommended 7 new medicines for approval, including:
☑️ 1st
https://nitter.cz/search?q=%23CRISPR
/Cas9 therapy to treat
https://nitter.cz/search?q=%23SickleCellDisease
&
https://nitter.cz/search?q=%23BetaThalassemia
☑️ a medicine for
https://nitter.cz/search?q=%23FriedreichsAtaxia
☑️ a medicine to treat
https://nitter.cz/search?q=%23Schistosomiasis
outside the 🇪🇺
https://europa.eu/!Qw3KK4
🐦🔗: https://nitter.cz/EMA_News/status/1735660079288840218#m
[2023-12-15 13:56 UTC]
R to @EMA_News: The 1st gene editing therapy to treat #SickleCellDisease & #BetaThalassemia recommended for approval by EMA's human medicines committee, is also the 1st medicine using a novel gene-editing technology (#CRISPR/Cas9) in the 🇪🇺.
🐦🔗: https://nitter.cz/EMA_News/status/1735660082413592605#m
[2023-12-15 13:56 UTC]
RT by @EMA_News: With the #EUGlobalHealthStrategy we’re striving to regain lost ground on the Sustainable Development #GlobalGoals, including our shared ambition to reach universal health coverage.
It’s time for a new era for #globalhealth.
🐦🔗: https://nitter.cz/EU_Health/status/1734595535636459748#m
[2023-12-12 15:26 UTC]
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.